Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis

American Journal of Ophthalmology

Volumn 152, Issue 4, 2011, Pages 628-637.e1

  Holbrook, Janet T ^a   Colvin, Ryan ^a   Van Natta, Mark L ^a   Thorne, Jennifer E ^a,b   Bardsley, Mark ^c   Jabs, Douglas A ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DEATH; DISEASE ACTIVITY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCORING SYSTEM; SURVIVAL RATE; SUSTAINED IMMUNE RECOVERY; UNITED STATES; VISUAL ACUITY;

EID: 80053339921     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.04.007     Document Type: Article

References (28)

1. D.A. Jabs, C. Enger, and J.G. Barlett Cytomegalovirus retinitis and acquired immunodeficiency syndrome Arch Ophthalmol 107 1 1989 75 80 (Pubitemid 19037328)
2. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Mortality in patients with acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N Engl J Med 326 4 1992 213 220
3. Studies of the Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Combination foscarnet and ganciclovir therapy vs. monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatment Trial Arch Ophthalmol 114 1 1996 23 33
4. D.A. Jabs, M.L. Van Natta, J.E. Thorne Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression Ophthalmology 111 12 2004 2224 2231 (Pubitemid 39585188)
5. D.A. Jabs, S.G. Bolton, J.P. Dunn, and A.G. Palestine Discontinuing anti-cytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy Am J Ophthalmol 126 6 1998 817 822 (Pubitemid 29001632)
6. T.R. Vrabec, V.F. Baldassano, and S.M. Whitcup Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts Ophthalmology 105 7 1998 1259 1264 (Pubitemid 28470897)
7. C. Tural, J. Romeu, and G. Sirera Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients J Infect Dis 177 4 1998 1080 1083 (Pubitemid 28155167)
8. J.C. MacDonald, F.J. Torriani, L.S. Morse, M.P. Karavellas, J.B. Reed, and W.R. Freeman Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy J Infect Dis 177 5 1998 1182 1187 (Pubitemid 28194255)
9. S.M. Whitcup, E. Fortin, and S. Lindblad Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis JAMA 282 17 1999 1633 1637 (Pubitemid 29513969)
10. J. Berenguer, J. Gonzalez, B. Pudilla, J.L. Casado, R. Rubio, J.R. Arribas Madrid Group for the Study of Discontinuation of Secondary Prophylaxis of patients with CMV retinitis Discontinuation of secondary prophylaxis in patients with cytomegalovirus who have responded to highly active antiretroviral therapy Clin Inf Dis 34 3 2002 394 397 (Pubitemid 34062243)
11. S.L. Walmsley, J. Raboud, and J.B. Angel Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis HIV Clin Trials 7 1 2006 1 9
12. Centers for Disease Control and Prevention 1999 USPHS/IDSA Guidelines for Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus MMWR 148 R10 1999 1 59
13. M.W. Stewart Optimal management of cytomegalovirus retinitis in patients with AIDS Clin Ophthalmol 4 2010 285 299
14. D.A. Jabs, M.L. Van Natta, and J.E. Thorne Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1 Retinitis progression Ophthalmology 111 12 2004 2224 2231 (Pubitemid 39585188)
15. D.A. Jabs, M.L. Van Natta, J.T. Holbrook, J.H. Kempen, C.L. Meinert, M.D. Davis Studies of the Ocular Complications of AIDS Research Group The Longitudinal Study of the Ocular Complications of AIDS: 1 Ocular diagnoses at enrollment Ophthalmology 114 4 2007 780 786
16. D.A. Jabs, M.L. Van Natta, and J.H. Kempen Characteristics of patients with CMV retinitis in the era of highly active anti-retroviral therapy (HAART) Am J Ophthalmol 133 1 2002 48 61 (Pubitemid 34076503)
17. Centers for Disease Control and Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 41 1991 1 19
18. F.L. Ferris III, A. Kassof, G.H. Bresnick, and I. Bailey New visual acuity charts for clinical research Am J Ophthalmol 94 1 1982 91 96 (Pubitemid 12080556)
19. Studies of Ocular Complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG) Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1 Rationale, design, and methods Control Clin Trials 13 1 1992 22 39
20. P.M. Tarwater, J. Mellors, and M.E. Gore Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts Am J Epidemiol 15 7 2001 675 681 4 (Pubitemid 32888786)
21. I.C. Huang, C. Frangakis, F. Dominici, G.B. Diette, and A.W. Wu Application of a propensity score approach for risk adjustment in profilings multiple physician groups on asthma care Health Serv Res 40 1 2005 253 278 (Pubitemid 40229359)
22. S.L. Zeger, and K.Y. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1 1986 121 130
23. D.A. Jabs, R.B. Nussenblatt, and J.T. Rosenbaum Standardization of uveitis nomenclature for reporting clinical data Am J Ophthalmol 140 3 2005 509 516
24. D.A. Jabs Cytomegalovirus retinitis and the acquired immunodeficiency syndromebench to bedside: LXVII Edward Jackson Memorial Lecture Am J Ophthalmol 151 2 2011 198 216
25. Centers for Disease Control and Prevention Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents MMWR 58 RR-4 2009 1 216
26. S.C. Johnson, C.A. Benson, D.W. Johnson, and A. Weinberg Recurrence of cytomegalovirus in a human immunodeficiency virus-infected patients, despite potent antiretroviral therapy and apparent immune restoration Clin Infect Dis 32 5 2001 815 819 (Pubitemid 32221942)
27. W.R. Freeman, M.L. Van Natta, and D.A. Jabs Vision function in the HIV-infected individuals without retinitis Am J Ophthamol 145 3 2008 453 462
28. G.N. Holland, P.J. Kappel, and M.L. Van Natta Association between abnormal contrast sensitivity and mortality among people with acquired immunodeficiency syndrome Am J Ophthalmol 149 5 2010 807 816